These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Progress and problems in the biology, diagnostics, and therapeutics of prion diseases. Aguzzi A, Heikenwalder M, Miele G. J Clin Invest; 2004 Jul; 114(2):153-60. PubMed ID: 15254579 [Abstract] [Full Text] [Related]
33. Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions. Caughey B, Baron GS, Chesebro B, Jeffrey M. Annu Rev Biochem; 2009 Aug 26; 78():177-204. PubMed ID: 19231987 [Abstract] [Full Text] [Related]
34. Amyloids, prions and the inherent infectious nature of misfolded protein aggregates. Soto C, Estrada L, Castilla J. Trends Biochem Sci; 2006 Mar 26; 31(3):150-5. PubMed ID: 16473510 [Abstract] [Full Text] [Related]
35. Silent prions lying in wait: a two-hit model of prion/amyloid formation and infection. Hall D, Edskes H. J Mol Biol; 2004 Feb 20; 336(3):775-86. PubMed ID: 15095987 [Abstract] [Full Text] [Related]
36. Generation of genuine prion infectivity by serial PMCA. Weber P, Giese A, Piening N, Mitteregger G, Thomzig A, Beekes M, Kretzschmar HA. Vet Microbiol; 2007 Aug 31; 123(4):346-57. PubMed ID: 17493773 [Abstract] [Full Text] [Related]
38. Molecular aspects of disease pathogenesis in the transmissible spongiform encephalopathies. Priola SA, Vorberg I. Methods Mol Biol; 2004 Aug 31; 268():517-40. PubMed ID: 15156065 [Abstract] [Full Text] [Related]
39. [Development of molecular target based-therapy for prion diseases]. Sakasegawa Y, Doh-ura K. Brain Nerve; 2007 Apr 31; 59(4):405-14. PubMed ID: 17447527 [Abstract] [Full Text] [Related]